Juan Sanchez - Intra Cellular Insider

Intra Cellular Therapies Inc -- USA Stock  

USD 15.88  0.2  1.24%

Vice President - Corporate Communications and Investor Relations

Dr. Juan F. Sanchez, M.D., is Vice President Corporationrationrate Communications of IntraCellular Therapies, Inc. Previously, he was a healthcare research analyst at investment banking firm Ladenburg Thalmann Co. Inc., with a deep focus on companies specializing in central nervous system diseases from 2008 to 2014, most recently as a Managing Director. Prior to that time, he was a Vice President of healthcare and nanotechnology equity research at investment banking firm Punk, Ziegel, Co. Dr. Sanchez received his Master in International Affairs from Columbia University and his MBA from University of Los Andes in Bogota, Colombia. Dr. Sanchez practiced medicine for five years in his native country, Colombia, having received a medical degree from Pontifical Xavierian University, in Bogota.
Age: 43  President Since 2014      
212 923-3344  www.intracellulartherapies.com

Management Efficiency

The company has return on total asset (ROA) of (16.4) % which means that it has lost $16.4 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (26.76) % meaning that it created substantial loss on money invested by shareholders.

Similar Executives

Entity Summary

IntraCellular Therapies, Inc., a biopharmaceutical company, discovers and develops small molecule drugs for the treatment of neuropsychiatric and neurologic disorders within the central nervous system . Intra Cellular Therapies Inc (ITCI) is traded on NASDAQ in USA. It is located in NEW YORK, U.S.A and employs 37 people. Intra Cellular is listed under Pharmaceutical Products category by Fama And French industry classification.

Did you try this?

Run Transaction History Now
   

Transaction History

View history of all your transactions and understand their impact on performance
Hide  View All  Next  Launch Transaction History
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Intra Cellular Therapies Inc to your portfolio

Top Management

Intra Cellular Thera Leadership Team
Lawrence Wennogle, President, Ph.D
Christopher Alafi, Director
Michael Rawlins, Director
Robert Nostrand, Director
Richard Lerner, Director
Robert Davis, President, Ph.D
Allen Fienberg, Founder, Ph.D
Michael Halstead, SVP
Sharon Mates, Chairman, Ph.D
Juan Sanchez, President
Rory Riggs, Director, MBA
Joel Marcus, Director
Kimberly Vanover, VP, Ph.D
Lawrence Hineline, President, CPA

Stock Performance

Intra Cellular Performance Indicators